A Two-Stage Ensemble Approach for Diabetes Prediction: Early Diagnosis with CatBoost and Advanced Diagnosis with LightGBM
Biomedical & Pharmacology Journal · 26.06.2026 · 2 (19) · 1682
DOI: 10.13005/bpj/3449 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical & Pharmacology Journal, online erschienen am 25.06.2026. Verfasst von Smita Kulkarni und 3 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetes is a common long-term sickness defined by elevated blood sugar levels as a result of impaired insulin physiological effects, faulty insulin secretion, or both. This condition can cause long-term damage and dysfunction to various tissues, including the kidneys, heart, blood vessels, eyes, and nerves. As living standards grow, diabetes is becoming increasingly common, making early and accurate detection crucial. This research focuses on predicting diabetes in two stages using machine learning. In this research, a two-stage approach was implemented for diabetes prediction using ensemble models. The first stage focused on the early diagnosis of diabetes to provide prior intimation about individuals’ health status. This involved using the Sylhet dataset, which contains comprehensive information for detecting prediabetes. In the second stage, the Frankfurt dataset was utilized, which includes numerical parameters for further diabetes diagnosis, to predict diabetes based on pathological parameters and to provide appropriate treatment to prevent further health issues.The article falls under the domain of Biomedical Signals and Medical Sciences, with its scope focusing on the early and advanced diagnosis of diabetes using machine learning ensemble models, involving medical data analysis, preprocessing, and the use of biomedical signals or patient health parameters. Various ensemble models were employed in both stages. In stage one, the Categorical Boosting(CatBoost) algorithm demonstrated superior performance for early diagnosis using the Sylhet dataset, while in stage two, the Light Gradient Boosting Machine(LightGBM) algorithm proved to be most effective for diabetes prediction using the Frankfurt dataset. Selecting the appropriate classifier and correct featuresa critical challenge for machine learning techniques in this domain. The findings suggest that ML models are beneficial for diabetes prediction and can significantly contribute to improving human health.Future research could compare these ensemble models against a deep learning technique, such as CNNs or RNNs, on both datasets to enhance accuracy for early and advanced diabetes prediction.
Zitieren
APA
Kulkarni, S., Hire, D., Charles, P., & Suryawanshi, S. (2026). A Two-Stage Ensemble Approach for Diabetes Prediction: Early Diagnosis with CatBoost and Advanced Diagnosis with LightGBM. Biomedical & Pharmacology Journal, 2(19), 1682. https://doi.org/10.13005/bpj/3449
Vancouver
Kulkarni S, Hire D, Charles P, Suryawanshi S. A Two-Stage Ensemble Approach for Diabetes Prediction: Early Diagnosis with CatBoost and Advanced Diagnosis with LightGBM. Biomedical & Pharmacology Journal. 2026;2(19):1682. doi:10.13005/bpj/3449
BibTeX
@article{Kulkarni2026,
author = {Kulkarni, Smita and Hire, Dnyanda and Charles, Priya and Suryawanshi, Shweta},
title = {A Two-Stage Ensemble Approach for Diabetes Prediction: Early Diagnosis with CatBoost and Advanced Diagnosis with LightGBM},
journal = {Biomedical & Pharmacology Journal},
year = {2026},
volume = {2},
number = {19},
pages = {1682},
doi = {10.13005/bpj/3449}
}
EUVIMED